Skip to main navigation Skip to search Skip to main content

Carbapenem-Resistant Enterobacterales Infection after Massive Blast Injury: Use of Cefiderocol Based Combination Therapy

  • B. W. Carney
  • , J. A. Rizzo
  • , J. F. Alderete
  • , R. Cindass
  • , A. E. Markelz
  • , L. C. Cancio

Research output: Contribution to journalArticlepeer-review

Abstract

A military soldier sustained a blast injury in Afghanistan, resulting in amputations and hemipelvectomy. He developed New Delhi metallo-beta-lactamase-producing E. coli bacteremia, soft-tissue infection, and sacral osteomyelitis. These organisms are being increasingly discovered in different communities around the world. He was successfully treated with tigecycline and cefiderocol. Cefiderocol is a novel siderophore-based cephalosporine developed to treat serious infections, including those caused by carbapenem-resistant Enterobacterales.

Original languageEnglish (US)
Pages (from-to)1241-1245
Number of pages5
JournalMilitary medicine
Volume186
Issue number11-12
DOIs
StatePublished - Nov 1 2021
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Carbapenem-Resistant Enterobacterales Infection after Massive Blast Injury: Use of Cefiderocol Based Combination Therapy'. Together they form a unique fingerprint.

Cite this